Company

Actinium Pharmaceuticals, Inc. (ATNM)

Standardized SEC financial data for Actinium Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001388320 · NYSE · Pharmaceutical Preparations.

Revenue growth (YoY)

11.1%

Return on equity

-432.6%

Free cash flow

-$24.7M

Debt / equity

0.12×

Current ratio

6.20×

EPS (diluted)

$-1.09

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	—	$1.1M	$1.0M	$81K	—	$90K
Cost of revenue	—	$900K	—	—	—	—
Gross profit	—	$244K	—	—

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$64.0M	$78.2M	$109.6M	$77.0M	$73.2M	$48.3M
Total current assets	$64.9M	$79.7M	$110.9M	$78.3M	$74.5M	$49.4M
Property, plant & equipment	$312K	$340K	$604K	$550K

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$21.6M	-$20.9M	$8.6M	-$47.3M	-$33.1M	-$24.6M
Capital expenditures	$253K	$133K	$366K	$153K	$11K	$104K
Free cash flow	-$21.9M	-$21.0M	$8.3M	-$47.5M

Get ATNM data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ATNM/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ATNM/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View ATNM filings on SEC EDGAR →